Free Trial

Nyxoah Q1 2024 Earnings Report

Nyxoah logo
$6.99 +0.49 (+7.54%)
As of 04:00 PM Eastern

Nyxoah EPS Results

Actual EPS
-$0.45
Consensus EPS
-$0.45
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Nyxoah Revenue Results

Actual Revenue
$1.33 million
Expected Revenue
$1.20 million
Beat/Miss
Beat by +$130.00 thousand
YoY Revenue Growth
N/A

Nyxoah Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

Conference Call Audio

Remove Ads

Nyxoah Earnings Headlines

Trump Treasure April 19
Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…
Kepler Capital Remains a Buy on Nyxoah (NYXH)
HC Wainwright Has Positive Outlook for Nyxoah Q1 Earnings
See More Nyxoah Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nyxoah? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nyxoah and other key companies, straight to your email.

About Nyxoah

Nyxoah (NASDAQ:NYXH), a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

View Nyxoah Profile

More Earnings Resources from MarketBeat